A research was conducted on rats in which it was found that the drug was used in the treatment of cancer. The use of the same drug in neurodegenerative diseases such as Alzheimer’s disease has shown very good results. Pennsylvania State University Stanford University Report Research by scientists at Pennsylvania State University, Stanford University and … Read more
By Vaishali Nambiar The interconnection of healthcare with IT has gotten deeper than one could have ever imagined. In 2022, the global healthcare IT market size was valued at $ 174.3 billion, with an expected CAGR of 18.2 per cent from 2023 to 2030, reaching $ 644.9 billion by 2030 In the realm of healthcare, … Read more
Waltham: To foster scientific collaboration between the R&D disciplines of drug discovery to the development of special chemical materials, Revvity, Inc. today announced the launch of its Signal Investigation Packagea unified, cloud-native SaaS platform. The new solution from Revvity Signals Software, the IT and software arm of Revvity, will be available worldwide. The SaaS platform … Read more
By Raj Srinivasaraghavan The cloud is engulfing more sectors, faster and deeper. Health and pharmaceuticals are an exception. Rather, the two sectors have been early adopters of the cloud and other futuristic technologies. Rather than being an enabler, the cloud has now become an inevitable technology for the industry in general and for new drug … Read more
By Nilesh Jahagirdar Artificial intelligence (AI) has prevailed in almost every business sector. However, in recent years, technology has disrupted the healthcare landscape, fueling innovations and showing the potential to help doctors and patients. From the early diagnosis of the disease, drug discovery and trials, and precision in patient monitoring for self-care, AI algorithms have … Read more